生存获益-话题@MedSci - 梅斯（MedSci）

#生存获益#

63篇内容 | 2588人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2006939, encodeId=f5182006939a5, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=NEJM：无论PD-L1表达水平帕博利珠单抗一线治疗转移性NSCLC鳞癌生存获益显著, objectType=article, longId=152644, objectId=1a4c15264424, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a4c15264424, replyNumber=0, likeNumber=62, createdTime=2019-04-19, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a4c15264424, moduleTitle=NEJM：无论PD-L1表达水平帕博利珠单抗一线治疗转移性NSCLC鳞癌生存获益显著, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1a4c15264424)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006937, encodeId=ab20200693ec2, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=Circulation：院内心脏骤停患者尽快除颤与肾上腺素治疗有长期生存获益吗？, objectType=article, longId=140881, objectId=dca61408816f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dca61408816f, replyNumber=0, likeNumber=61, createdTime=2018-07-30, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dca61408816f, moduleTitle=Circulation：院内心脏骤停患者尽快除颤与肾上腺素治疗有长期生存获益吗？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=dca61408816f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006935, encodeId=bb3820069351e, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=J Hepatol：CHC患者发生慢性肾脏疾病的风险更高，血液透析患者抗病毒治疗后生存获益, objectType=article, longId=127902, objectId=f5aa12e90269, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5aa12e90269, replyNumber=0, likeNumber=66, createdTime=2018-06-19, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5aa12e90269, moduleTitle=J Hepatol：CHC患者发生慢性肾脏疾病的风险更高，血液透析患者抗病毒治疗后生存获益, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f5aa12e90269)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006934, encodeId=5166200693402, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=J Hepatol：哪些因素会影响索拉菲尼治疗肝细胞癌的生存获益？, objectType=article, longId=122408, objectId=eb6412240877, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb6412240877, replyNumber=0, likeNumber=0, createdTime=2018-02-16, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb6412240877, moduleTitle=J Hepatol：哪些因素会影响索拉菲尼治疗肝细胞癌的生存获益？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=eb6412240877)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006931, encodeId=c1b1200693113, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=Ann Rheum Dis：强直性脊柱炎服用他汀类药物的生存获益, objectType=article, longId=105520, objectId=e0c310552094, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0c310552094, replyNumber=0, likeNumber=89, createdTime=2017-08-09, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0c310552094, moduleTitle=Ann Rheum Dis：强直性脊柱炎服用他汀类药物的生存获益, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e0c310552094)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006930, encodeId=8b32200693059, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=JAMA：机械通气的败血症患者：右美托咪定镇静是否有生存获益？, objectType=article, longId=96612, objectId=388d96612a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=388d96612a7, replyNumber=0, likeNumber=106, createdTime=2017-06-03, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=388d96612a7, moduleTitle=JAMA：机械通气的败血症患者：右美托咪定镇静是否有生存获益？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=388d96612a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006929, encodeId=99672006929f9, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=JAMA Intern Med：养老院老年AMI患者处方β-受体阻滞剂有无生存获益？, objectType=article, longId=91992, objectId=e29c919926f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e29c919926f, replyNumber=0, likeNumber=108, createdTime=2017-12-24, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e29c919926f, moduleTitle=JAMA Intern Med：养老院老年AMI患者处方β-受体阻滞剂有无生存获益？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e29c919926f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006933, encodeId=09c4200693355, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=Lancet：Nivolumab为晚期胃癌或胃-食管结合部肿瘤患者带来生存获益, objectType=article, longId=116277, objectId=b63e1162e77c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b63e1162e77c, replyNumber=0, likeNumber=70, createdTime=2018-05-19, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b63e1162e77c, moduleTitle=Lancet：Nivolumab为晚期胃癌或胃-食管结合部肿瘤患者带来生存获益, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b63e1162e77c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006932, encodeId=7462200693283, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=J CLIN ONCOL：延长无铂间期能否为铂类部分敏感的卵巢癌患者带来生存获益？, objectType=article, longId=110935, objectId=b32d110935ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b32d110935ca, replyNumber=0, likeNumber=0, createdTime=2017-12-01, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b32d110935ca, moduleTitle=J CLIN ONCOL：延长无铂间期能否为铂类部分敏感的卵巢癌患者带来生存获益？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b32d110935ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006928, encodeId=18db2006928ee, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=JCO：诺乙雄龙可以明显提高老年AML患者的生存获益(GOELAMS 研究), objectType=article, longId=81481, objectId=f3c1814819b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3c1814819b, replyNumber=0, likeNumber=80, createdTime=2017-07-02, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3c1814819b, moduleTitle=JCO：诺乙雄龙可以明显提高老年AML患者的生存获益(GOELAMS 研究), moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f3c1814819b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006927, encodeId=6da7200692e6a, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=Lancet：腔内动脉瘤修补术的长期生存获益逊色于开放性修补术, objectType=article, longId=80061, objectId=953980061cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=953980061cd, replyNumber=0, likeNumber=65, createdTime=2017-06-19, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=953980061cd, moduleTitle=Lancet：腔内动脉瘤修补术的长期生存获益逊色于开放性修补术, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=953980061cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006925, encodeId=9f482006925f3, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=NEJM：缺血性心肌病患者通过冠状动脉旁路移植术有很好的生存获益, objectType=article, longId=66553, objectId=eb1d665537c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb1d665537c, replyNumber=0, likeNumber=99, createdTime=2016-09-04, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb1d665537c, moduleTitle=NEJM：缺血性心肌病患者通过冠状动脉旁路移植术有很好的生存获益, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=eb1d665537c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006926, encodeId=60992006926af, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=Gastroenterology：肝硬化Child-PughA或B级患者应用辛伐他汀或具生存获益(附MedSci解读), objectType=article, longId=69923, objectId=3f0f6992392, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f0f6992392, replyNumber=0, likeNumber=76, createdTime=2017-02-24, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f0f6992392, moduleTitle=Gastroenterology：肝硬化Child-PughA或B级患者应用辛伐他汀或具生存获益(附MedSci解读), moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3f0f6992392)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006924, encodeId=07b820069248e, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=PD-1免疫疗法Opdivo治疗鳞状肺癌表现出持续生存获益（CheckMate-017，CheckMate-063研究）, objectType=article, longId=56040, objectId=67d956040cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67d956040cd, replyNumber=0, likeNumber=71, createdTime=2015-10-16, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67d956040cd, moduleTitle=PD-1免疫疗法Opdivo治疗鳞状肺癌表现出持续生存获益（CheckMate-017，CheckMate-063研究）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=67d956040cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006923, encodeId=e7b320069237d, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=ASCO 2015：PD-1单抗治疗进展期肾癌带来生存获益, objectType=article, longId=51707, objectId=aa4151e07fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa4151e07fc, replyNumber=0, likeNumber=73, createdTime=2015-11-28, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa4151e07fc, moduleTitle=ASCO 2015：PD-1单抗治疗进展期肾癌带来生存获益, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=aa4151e07fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006921, encodeId=b3b5200692166, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=Heart：CRT-D未产生额外生存获益, objectType=article, longId=32922, objectId=ca2c32922b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca2c32922b1, replyNumber=0, likeNumber=71, createdTime=2014-04-27, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca2c32922b1, moduleTitle=Heart：CRT-D未产生额外生存获益, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ca2c32922b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006919, encodeId=c9e62006919a4, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=Ann Surg：广西医科大学钟鉴宏等发现肝脏切除治疗BCLC B/C期肝细胞癌可取得较佳生存获益, objectType=article, longId=25283, objectId=c24c25283f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c24c25283f0, replyNumber=0, likeNumber=63, createdTime=2014-05-06, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c24c25283f0, moduleTitle=Ann Surg：广西医科大学钟鉴宏等发现肝脏切除治疗BCLC B/C期肝细胞癌可取得较佳生存获益, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c24c25283f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006918, encodeId=f19f20069185b, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=JCO:早期子宫内膜癌患者进行盆腔外照射放疗不能取得生存获益, objectType=article, longId=24537, objectId=548f2453e46, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=548f2453e46, replyNumber=0, likeNumber=113, createdTime=2014-02-18, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=548f2453e46, moduleTitle=JCO:早期子宫内膜癌患者进行盆腔外照射放疗不能取得生存获益, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=548f2453e46)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006922, encodeId=cd562006922e4, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=CJASN：急性肾衰患者透析能使患者生存获益（倾向匹配分析）, objectType=article, longId=33872, objectId=d403338e2a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d403338e2a6, replyNumber=0, likeNumber=64, createdTime=2014-06-24, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d403338e2a6, moduleTitle=CJASN：急性肾衰患者透析能使患者生存获益（倾向匹配分析）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d403338e2a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006917, encodeId=81c9200691eea, content=<a href='/topic/show?id=52ad6902144' target=_blank style='color:#2F92EE;'>#生存获益#</a>, objectTitle=JCO：伊班膦酸钠辅助治疗早期淋巴结阳性乳腺癌无生存获益, objectType=article, longId=24036, objectId=4d552403677, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d552403677, replyNumber=0, likeNumber=73, createdTime=2014-05-28, rootId=0, userName=ms8538335253054589, userId=8e712500159, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d552403677, moduleTitle=JCO：伊班膦酸钠辅助治疗早期淋巴结阳性乳腺癌无生存获益, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4d552403677)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存获益

2020-05-29

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

NEJM：无论PD-L1表达水平帕博利珠单抗一线治疗转移性NSCLC鳞癌生存获益显著

2019-04-19

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

Circulation：院内心脏骤停患者尽快除颤与肾上腺素治疗有长期生存获益吗？

2018-07-30

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

J Hepatol：CHC患者发生慢性肾脏疾病的风险更高，血液透析患者抗病毒治疗后生存获益

2018-06-19

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

J Hepatol：哪些因素会影响索拉菲尼治疗肝细胞癌的生存获益？

2018-02-16

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

Ann Rheum Dis：强直性脊柱炎服用他汀类药物的生存获益

2017-08-09

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

JAMA：机械通气的败血症患者：右美托咪定镇静是否有生存获益？

2017-06-03

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

JAMA Intern Med：养老院老年AMI患者处方β-受体阻滞剂有无生存获益？

2017-12-24

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

Lancet：Nivolumab为晚期胃癌或胃-食管结合部肿瘤患者带来生存获益

2018-05-19

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

J CLIN ONCOL：延长无铂间期能否为铂类部分敏感的卵巢癌患者带来生存获益？

2017-12-01

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

JCO：诺乙雄龙可以明显提高老年AML患者的生存获益(GOELAMS 研究)

2017-07-02

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

Lancet：腔内动脉瘤修补术的长期生存获益逊色于开放性修补术

2017-06-19

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

NEJM：缺血性心肌病患者通过冠状动脉旁路移植术有很好的生存获益

2016-09-04

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

Gastroenterology：肝硬化Child-PughA或B级患者应用辛伐他汀或具生存获益(附MedSci解读)

2017-02-24

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

PD-1免疫疗法Opdivo治疗鳞状肺癌表现出持续生存获益（CheckMate-017，CheckMate-063研究）

2015-10-16

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

ASCO 2015：PD-1单抗治疗进展期肾癌带来生存获益

2015-11-28

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

Heart：CRT-D未产生额外生存获益

2014-04-27

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

Ann Surg：广西医科大学钟鉴宏等发现肝脏切除治疗BCLC B/C期肝细胞癌可取得较佳生存获益

2014-05-06

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

JCO:早期子宫内膜癌患者进行盆腔外照射放疗不能取得生存获益

2014-02-18

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

CJASN：急性肾衰患者透析能使患者生存获益（倾向匹配分析）

2014-06-24

ms8538335253054589 (审核中...)

前往app查看评论内容

#生存获益#

JCO：伊班膦酸钠辅助治疗早期淋巴结阳性乳腺癌无生存获益

2014-05-28

科室
- - 订阅+
  - 更多科室
工具
服务